Immunovia advances strategic collaboration with primary care physicians in the US to build awareness of the importance of early detection of pancreatic cancer
LUND, SWEDEN - Immunovia AB (publ.) (“Immunovia”) today announced its continued commitment to its strategic initiative of collaborating with primary care physicians (PCPs) in the US that are united in their goal of detecting pancreatic cancer early. This initiative began in 2018 with Immunovia’s educational program for PCPs at Fenway Park on World Pancreatic Cancer Day . The program highlighted the important role that primary care physicians can play in detecting pancreatic adenocarcinoma early in patients. In early March of this